TG-2349, a Potent Protease Inhibitor, Plus Pegifn/RBV Provides Excellent Virological Responses for Harder-To-Treat Subpopulations of HCV-1B Non-Cirrhotic Patients

Yu, M.-L.; Hsu, S.-J.; Yeh, C.-T.; Hung, C.-H.; Chen, M.-Y.; Chen, P.-J.; Huang, Y.- H.; Cheng, P.-N.; Chen, C.-M.; Chang, L.-W.; Lin, C.-C.; Sheen, F.; King, C.-H.R.; Kuo, E.; Hsu, M.-C.

期刊名称Journal of Hepatology
作者Yu, M.-L.; Hsu, S.-J.; Yeh, C.-T.; Hung, C.-H.; Chen, M.-Y.; Chen, P.-J.; Huang, Y.- H.; Cheng, P.-N.; Chen, C.-M.; Chang, L.-W.; Lin, C.-C.; Sheen, F.; King, C.-H.R.; Kuo, E.; Hsu, M.-C.
卷第64卷
期第2期
印刷ISSN0168-8278
文件大小71.96KB
发表时间2016
DOI10.1016/s0168-8278(16)01559-2

发现好书期刊，享受阅读乐趣

TG-2349, a Potent Protease Inhibitor, Plus Pegifn/RBV Provides Excellent Virological Responses for Harder-To-Treat Subpopulations of HCV-1B Non-Cirrhotic Patients